This study aims to evaluate the clinical value of commercially available AI products for intracranial hemorrhage (ICH) management by assessing the available scientific evidence. In addition, it seeks to indicate the current status, shed light on knowledge gaps, and assist in making informed decisions regarding their integration into clinical practice, considering their impact on diagnostic accuracy, workflow efficiency, patient outcomes, and overall healthcare system benefits.